What is Veracyte's long-term investments?

Veracyte (VCYT) reported long-term investments of $50.31M in Q4 2025.

What does long-term investments mean?

Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.

Veracyte VCYT Long-term investments

Long-term investments at other companies

Bio-Rad LaboratoriesBIO

——

Labcorp HoldingsLH

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's long-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's long-term investments?: Veracyte (VCYT) reported long-term investments of $50.31M in Q4 2025.
What does long-term investments mean?: Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.